Efficacy of PSMA PET-Guided Radiotherapy for Oligometastatic Castrate-Resistant Prostate Cancer

PURPOSE: To assess the outcome of radiotherapy (RT) to all PSMA ligand positive metastases for patients with castrate-resistant prostate cancer (mCRPC). PATIENTS AND METHODS: A total of 42 patients developed oligometastatic mCRPC and received PSMA PET-guided RT of all metastases. The main outcome pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Henkenberens, Christoph, Derlin, Thorsten, Bengel, Frank, Ross, Tobias L., Kuczyk, Markus A., Giordano, Frank A., Sarria, Gustavo R., Schmeel, Leonard Christopher, Christiansen, Hans, von Klot, Christoph A. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089391/
https://www.ncbi.nlm.nih.gov/pubmed/33954116
http://dx.doi.org/10.3389/fonc.2021.664225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089391/
https://www.ncbi.nlm.nih.gov/pubmed/33954116
http://dx.doi.org/10.3389/fonc.2021.664225

Ejemplares similares